ArticleJournal of cardiovascular development and disease2022
Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1.
Qiang Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.